A Randomised Trial of a Weight Loss Intervention for Overweight and Obese People Diagnosed with Coronary Heart Disease and/or Type 2 Diabetes
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Weight reduction limits disease progression in obese people with coronary heart disease (CHD) and/or type 2 diabetes mellitus (T2DM).
To test a 16-week group-based weight reduction intervention combining exercise, diet and behaviour change strategies aimed to increase self-efficacy (Healthy Eating and Exercise Lifestyle Program—HEELP) on weight, body mass index (BMI), waist circumference and exercise.
Participants with CHD and/or T2DM and BMI between 27 to 39 kg/m2 were randomised to HEELP (n = 83) or usual care (n = 65).
Participants were aged a mean 63.47 years (SD 8.9), male (58 %) and Caucasian (79 %). HEELP participants lost significantly more weight, BMI and waist circumference and exercised more days/week for a longer duration/week than usual care. Clinically significant weight loss (≥5 %) was more common in HEELP than usual care.
The HEELP resulted in weight loss and improved exercise behaviour in obese people with CHD and T2DM.
- A Randomised Trial of a Weight Loss Intervention for Overweight and Obese People Diagnosed with Coronary Heart Disease and/or Type 2 Diabetes
Annals of Behavioral Medicine
Volume 44, Issue 1 , pp 119-128
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Coronary heart disease
- Type II diabetes
- Weight reduction
- Behaviour change
- Industry Sectors
- Author Affiliations
- 1. Faculty of Nursing, Midwifery and Health, The University of Technology, Sydney, PO Box 123, Broadway, NSW, 2007, Australia
- 2. North Shore Cardiovascular Education Centre, Royal North Shore Hospital, Sydney, Australia
- 3. Diabetes Education Service, Royal North Shore Hospital, Sydney, Australia
- 4. Northern Sydney Clinical School, Royal North Shore Hospital, Sydney, Australia